Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Expression of the human PAC1 receptor leads to dose-dependent hydrocephalus-related abnormalities in mice
Bing Lang, … , Anthony J. Harmar, Sanbing Shen
Bing Lang, … , Anthony J. Harmar, Sanbing Shen
Published July 3, 2006
Citation Information: J Clin Invest. 2006;116(7):1924-1934. https://doi.org/10.1172/JCI27597.
View: Text | PDF
Research Article Neuroscience

Expression of the human PAC1 receptor leads to dose-dependent hydrocephalus-related abnormalities in mice

  • Text
  • PDF
Abstract

Hydrocephalus is a common and potentially devastating birth defect affecting the CNS, and its relationship with G protein–coupled receptors (GPCRs) is unknown. We have expressed 2, 4, or 6 copies of a GPCR — the human PAC1 receptor with a 130-kb transgene in the mouse nervous system in a pattern closely resembling that of the endogenous gene. Consistent with PAC1 actions, PKA and PKC activity were elevated in the brains of Tg mice. Remarkably, Tg mice developed dose-dependent hydrocephalus-like characteristics, including enlarged third and lateral ventricles and reduced cerebral cortex, corpus callosum, and subcommissural organ (SCO). Neuronal proliferation and apoptosis were implicated in hydrocephalus, and we observed significantly reduced neuronal proliferation and massively increased neuronal apoptosis in the developing cortex and SCO of Tg embryos, while neurite outgrowth and neuronal migration in vitro remain uncompromised. Ventricular ependymal cilia are crucial for directing cerebrospinal fluid flow, and ependyma of Tg mice exhibited disrupted cilia with increased phospho-CREB immunoreactivity. These data demonstrate that altered neuronal proliferation/apoptosis and disrupted ependymal cilia are the main factors contributing to hydrocephalus in PAC1-overexpressing mice. This is the first report to our knowledge demonstrating that misregulation of GPCRs can be involved in hydrocephalus-related neurodevelopmental disorders.

Authors

Bing Lang, Bing Song, Wendy Davidson, Alastair MacKenzie, Norman Smith, Colin D. McCaig, Anthony J. Harmar, Sanbing Shen

×

Figure 7

Decreased proliferation and increased apoptosis in E15.

Options: View larger image (or click on image) Download as PowerPoint
Decreased proliferation and increased apoptosis in E15.
 Tg embryos. (A–...
Tg embryos. (A–D) BrdU labeling of transverse sections of E15.5 Tg embryos and WT littermates. C and D are higher-power views of the boxed areas in A and B, respectively. Note the substantial reduction in BrdU incorporation in Tg embryos. (E and F) TUNEL assay of coronal sections of E15.5 WT (E) and Tg (F) embryos, demonstrating remarkable increases in apoptosis in the developing SCO (boxed areas, arrows), cortex (cortical plate and marginal zone in particular), and ventricular ependymal cells (arrowheads) in Tg embryos. (G and H) Higher magnification of the SCO in E and F. TUNEL-labeled cells (I) in E15.5 cortex were quantified from 0.038 mm2 of 3 sections of each embryo (WT, n = 4; Tg, n = 4). The number of BrdU-positive cells (J) or the total number of cells (J) and their ratios (K) within 0.01 mm2 of the proliferating zones of E15.5 cortex were quantified from 5 WT and 5 Tg embryos, showing significantly reduced neuronal proliferation. **P <0.01. CsL, corpus striatum laterale; CsM, corpus striatum mediale. Scale bars: 400 μm in A, B, E, and F; 100 μm in C, D, G, and H.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts